PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
July 21, 20250 citations

Computational Analysis of Post-Translational Modifications in Diabetes: A Systems Biology and Structure-Based Drug Discovery Approach

View Full Paper
AFAhmed El fakiHFHussein FayedAMA. Mahmoud

Key Points

  • Computational analysis identifies how post-translational modifications influence protein function in diabetes.
  • Key proteins include AKT2, IRS1, FoxO1, and PDX1, which have significant roles in metabolic regulation.
  • The study utilized molecular docking and dynamics simulations to evaluate protein modifications and binding affinities.
  • Results support targeting post-translationally modified proteins for new diabetes treatments and experimental validation.

Abstract

Abstract: Post-translational modifications (PTMs) regulate protein function, stability, and interaction networks, and are involved in the pathophysiology of diabetes mellitus through modulation of insulin signaling, β-cell function, and glucose metabolism. Aberrant PTMs contribute to insulin resistance, β-cell apoptosis, and metabolic dysregulation. This study applies a computational framework integrating molecular docking, molecular dynamics (MD) simulations, and virtual screening to investigate the structural and functional impact of PTMs on key diabetes-related proteins. Structural models incorporating phosphorylation, acetylation, ubiquitination, SUMOylation, and methylation were generated to assess conformational changes and ligand binding alterations. Proteins such as AKT2, IRS1, FoxO1, and PDX1 were prioritized based on their functional relevance and PTM profiles. Virtual screening of chemical libraries against PTM-modified protein structures, followed by MD simulations and free energy calculations, was conducted to identify small molecules capable of modulating PTM-influenced sites. Binding affinities, conformational stability, and drug-likeness parameters were analyzed to prioritize compounds for further investigation. The results provide a computational basis for targeting PTM-modified proteins in diabetes, supporting future experimental validation and development of PTM-focused therapeutic strategies.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

faki et al. (2025) studied this question.

synapsesocial.com/papers/68af4ec0ad7bf08b1ead7b66https://doi.org/10.63850/ijbtcs-cps.v1.i1.a11
Ask AI
Helpful
Bookmark
Share
View Full Paper